Behandlingsnaive, gravide kvinder blev indrulleret i undersøgelsen i graviditetsuge 34- 36 og fik antiretroviral behandling frem til fødslen.
Treatment naive pregnant women were enrolled into the study at gestation week 34-36 and given antiretroviral treatment until delivery.